QuintilesIMS, Salesforce launch multi-year venture

By Melissa Fassbender contact

- Last updated on GMT

QuintilesIMS announces alliance with Salesforce to build next gen solutions for life sciences firms. (Image: iStock/ipopba)
QuintilesIMS announces alliance with Salesforce to build next gen solutions for life sciences firms. (Image: iStock/ipopba)

Related tags: Artificial intelligence, Life

QuintilesIMS has announced an alliance with Salesforce through which the companies aim to “equip and enable” customers to meet future healthcare challenges.

The agreement, terms of which were not disclosed, is a multi-year venture that will operate on a global scale.

Tal Rosenberg, Senior Vice President, Technology Solutions, QuintilesIMS told us the company is building new solutions to complement its existing ones, “taking advantage of [Salesforces’] built-in cloud, mobile, social and artificial intelligence capabilities​,” he said.

By building apps on the Salesforce Platform, which is updated three times a year, Rosenberg said QuintilesIMS can focus on its areas of differentiation.

These applications will help life science companies drive patient recruitment, manage clinical trials, marketing and other key activities as they bring new therapies to market​,” he explained, adding that the company will initially work with Salesforce on apps in these areas.

Long term, QuintilesIMS will work with Salesforce in new areas, such as digital health, precision medicine and patient engagement, by leveraging artificial intelligence (AI) and Internet of Things (IoT) technologies as part of the Salesforce Platform.

The partnership will ultimately help customers bring new therapies to market faster and more efficiently – taking advantage of the latest in cloud, mobile, social and artificial intelligence technologies​,” said Rosenberg.

“This alliance has transformative potential for the life sciences industry, as it will better equip and enable our mutual customers to meet the challenges they face as they move healthcare forward​.”

Related news

Show more

Related products

show more

A Winning End-to-End Solution for Oncology Studies

A Winning End-to-End Solution for Oncology Studies

Clinical Ink | 22-Feb-2021 | Technical / White Paper

Oncology clinical trials present a unique set of challenges for patients, study sites, and study sponsors. Using electronic patient reported outcomes (ePRO)...

Vaccine Innovation in the Era of COVID19

Vaccine Innovation in the Era of COVID19

Covance Patient Safety | 01-Oct-2020 | Sponsored Link

During this time of worldwide crisis, there is an increasing demand for the acceleration of a vaccination for COVID19. Regardless of the great recent advancements...

Related suppliers

Follow us

Products

View more

Webinars